Item Type | Name |
Concept
|
Interferon beta-1a
|
Concept
|
Adenoviridae
|
Concept
|
Adjuvants, Immunologic
|
Concept
|
Administration, Intravaginal
|
Concept
|
Analysis of Variance
|
Concept
|
Administration, Topical
|
Concept
|
Aneuploidy
|
Concept
|
Animals
|
Concept
|
Haplorhini
|
Concept
|
Anti-Inflammatory Agents
|
Concept
|
Antibodies
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Antibodies, Viral
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
Antigens, Viral
|
Concept
|
Alzheimer Disease
|
Concept
|
Amino Acid Sequence
|
Concept
|
Acute Disease
|
Concept
|
Axons
|
Concept
|
B-Lymphocytes
|
Concept
|
Blood-Retinal Barrier
|
Concept
|
Base Sequence
|
Concept
|
Brain Stem
|
Concept
|
Cell Count
|
Concept
|
Cell Line
|
Concept
|
Cell Movement
|
Concept
|
Dendritic Cells
|
Concept
|
Cornea
|
Concept
|
Corneal Diseases
|
Concept
|
Corneal Opacity
|
Concept
|
Corneal Ulcer
|
Concept
|
Dexamethasone
|
Concept
|
Eye
|
Concept
|
Endoribonucleases
|
Concept
|
Complement C3
|
Concept
|
Feasibility Studies
|
Concept
|
Enzyme Induction
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Ependyma
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Escherichia coli
|
Concept
|
Murine hepatitis virus
|
Concept
|
Hepatitis, Viral, Animal
|
Concept
|
Estrogens
|
Concept
|
Herpes Genitalis
|
Concept
|
Herpes Simplex
|
Concept
|
Electroretinography
|
Concept
|
Humans
|
Concept
|
Encephalitis
|
Concept
|
Glial Fibrillary Acidic Protein
|
Concept
|
Lipopolysaccharides
|
Concept
|
Keratitis
|
Concept
|
Killer Cells, Natural
|
Concept
|
Lymph Nodes
|
Concept
|
Lymphocyte Activation
|
Concept
|
Macrophages
|
Concept
|
Macular Degeneration
|
Concept
|
Granulocytes
|
Concept
|
Inflammation
|
Concept
|
Mandible
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Neutrophils
|
Concept
|
Leukocytes
|
Concept
|
Multiple Sclerosis
|
Concept
|
Interferon Type I
|
Concept
|
Interferon-gamma
|
Concept
|
Interferons
|
Concept
|
Iris
|
Concept
|
Neovascularization, Pathologic
|
Concept
|
Nerve Degeneration
|
Concept
|
Nerve Regeneration
|
Concept
|
Viral Plaque Assay
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mice, Inbred DBA
|
Concept
|
Mice, Inbred ICR
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Mice, Transgenic
|
Concept
|
Poly dA-dT
|
Concept
|
Poly I-C
|
Concept
|
Microscopy, Fluorescence
|
Concept
|
Mitosis
|
Concept
|
Molecular Sequence Data
|
Concept
|
Salmonella typhimurium
|
Concept
|
Retrospective Studies
|
Concept
|
Sympathectomy, Chemical
|
Concept
|
Sympathetic Nervous System
|
Concept
|
Synovial Membrane
|
Concept
|
T-Lymphocytes
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Tears
|
Concept
|
Radiation Chimera
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
Receptors, Fc
|
Concept
|
Trans-Activators
|
Concept
|
Recurrence
|
Concept
|
Spleen
|
Concept
|
2',5'-Oligoadenylate Synthetase
|
Concept
|
Blotting, Western
|
Concept
|
Antigens, CD
|
Concept
|
Eye Infections
|
Concept
|
Eye Infections, Bacterial
|
Concept
|
Eye Infections, Viral
|
Concept
|
Substance P
|
Concept
|
CD3 Complex
|
Concept
|
Medroxyprogesterone Acetate
|
Concept
|
CD8 Antigens
|
Concept
|
Keratitis, Herpetic
|
Concept
|
Vaccination
|
Concept
|
Vaccines, Attenuated
|
Concept
|
Interferon-alpha
|
Concept
|
Interferon-beta
|
Concept
|
Receptors, Interferon
|
Concept
|
Vero Cells
|
Concept
|
Viral Vaccines
|
Concept
|
Encephalitis, Viral
|
Concept
|
Vision, Ocular
|
Concept
|
Visual Acuity
|
Concept
|
Nystagmus, Optokinetic
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Cyclin-Dependent Kinases
|
Concept
|
Vitreous Body
|
Concept
|
Homeodomain Proteins
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
CpG Islands
|
Concept
|
Chemokines
|
Concept
|
Cell Culture Techniques
|
Concept
|
Antineoplastic Agents, Hormonal
|
Concept
|
Microscopy, Confocal
|
Concept
|
Lymphocyte Count
|
Concept
|
Interleukin-12
|
Concept
|
Transgenes
|
Concept
|
Fluorescent Antibody Technique, Indirect
|
Concept
|
Corneal Neovascularization
|
Concept
|
Mice, SCID
|
Concept
|
Tacrolimus
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Lateral Ventricles
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Choroidal Neovascularization
|
Concept
|
Matrix Metalloproteinase 9
|
Concept
|
Encephalitis, Herpes Simplex
|
Concept
|
Simplexvirus
|
Concept
|
Trigeminal Nerve Diseases
|
Concept
|
Herpesvirus 2, Human
|
Concept
|
Herpesvirus 1, Human
|
Concept
|
Mice, Knockout
|
Concept
|
Coronavirus Infections
|
Concept
|
Receptors, Chemokine
|
Concept
|
Receptors, CCR5
|
Concept
|
Chemokines, CC
|
Concept
|
Chemokines, CXC
|
Concept
|
eIF-2 Kinase
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Drug Resistance, Viral
|
Concept
|
Pseudomonas aeruginosa
|
Concept
|
Pseudomonas Infections
|
Concept
|
Ubiquitin-Protein Ligases
|
Concept
|
Toll-Like Receptors
|
Concept
|
Toll-Like Receptor 4
|
Concept
|
Toll-Like Receptor 9
|
Concept
|
Caveolin 1
|
Concept
|
Mice
|
Concept
|
Sphingolipids
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Tyrosine 3-Monooxygenase
|
Concept
|
Neurogenesis
|
Concept
|
Ultraviolet Rays
|
Concept
|
Interleukin-6
|
Concept
|
Gene Expression
|
Concept
|
Complement C3d
|
Concept
|
RNA, Small Interfering
|
Concept
|
Survival Analysis
|
Concept
|
Immunophenotyping
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Receptor, Macrophage Colony-Stimulating Factor
|
Concept
|
Cytokines
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
Fibroblast Growth Factor 2
|
Concept
|
Amyloid beta-Peptides
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Leukocyte Reduction Procedures
|
Concept
|
Administration, Ophthalmic
|
Concept
|
Cell Proliferation
|
Concept
|
Green Fluorescent Proteins
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
Concept
|
Vascular Endothelial Growth Factor Receptor-3
|
Concept
|
Osteopontin
|
Concept
|
Proteomics
|
Concept
|
Tomography, Optical Coherence
|
Concept
|
Leukemia Inhibitory Factor Receptor alpha Subunit
|
Concept
|
Adoptive Transfer
|
Concept
|
Vascular Endothelial Growth Factor A
|
Concept
|
Transforming Growth Factor beta1
|
Concept
|
Granzymes
|
Concept
|
Macrophage Inflammatory Proteins
|
Concept
|
Vascular Endothelial Growth Factor C
|
Concept
|
Lymphangiogenesis
|
Concept
|
Lymphatic Vessels
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
Viral Load
|
Concept
|
Epithelium, Corneal
|
Concept
|
Antibodies, Neutralizing
|
Concept
|
STAT1 Transcription Factor
|
Concept
|
STAT3 Transcription Factor
|
Concept
|
STAT5 Transcription Factor
|
Concept
|
HEK293 Cells
|
Concept
|
Chemokine CXCL10
|
Concept
|
Chemokine CXCL1
|
Concept
|
Receptors, CXCR3
|
Concept
|
Chemokine CXCL9
|
Concept
|
Chemokine CCL3
|
Concept
|
Chemokine CCL4
|
Concept
|
Herpes Simplex Virus Vaccines
|
Concept
|
Nestin
|
Concept
|
Chlamydia muridarum
|
Concept
|
Collagen Type II
|
Concept
|
Intravitreal Injections
|
Concept
|
Bacterial Load
|
Concept
|
Cell Line, Tumor
|
Concept
|
Pore Forming Cytotoxic Proteins
|
Concept
|
Immunity, Humoral
|
Concept
|
Disease Resistance
|
Concept
|
Corneal Keratocytes
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
B7-H1 Antigen
|
Concept
|
Programmed Cell Death 1 Ligand 2 Protein
|
Concept
|
Antiviral Agents
|
Concept
|
Arthritis, Experimental
|
Concept
|
Cells, Cultured
|
Concept
|
Chemotaxis, Leukocyte
|
Concept
|
Chlamydia Infections
|
Concept
|
Disease Models, Animal
|
Concept
|
Disease Susceptibility
|
Concept
|
DNA, Viral
|
Concept
|
Flow Cytometry
|
Concept
|
Immunity, Cellular
|
Concept
|
Immunization
|
Concept
|
Immunization, Passive
|
Concept
|
Immunization, Secondary
|
Concept
|
Immunohistochemistry
|
Concept
|
Immunologic Surveillance
|
Concept
|
Olfactory Bulb
|
Concept
|
Oligodeoxyribonucleotides
|
Concept
|
Organ Culture Techniques
|
Academic Article
|
Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.
|
Academic Article
|
"Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
|
Academic Article
|
Microglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitis.
|
Academic Article
|
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
|
Academic Article
|
Large-scale generation of plasmids that express type I interferon.
|
Academic Article
|
Dichotomy between survival and lytic gene expression in RNase L- and PKR-deficient mice transduced with an adenoviral vector expressing murine IFN-beta following ocular HSV-1 infection.
|
Academic Article
|
Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1.
|
Academic Article
|
Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?
|
Academic Article
|
CXCL10 expressing hematopoietic-derived cells are requisite in defense against HSV-1 infection in the nervous system of CXCL10 deficient mice.
|
Academic Article
|
Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection.
|
Academic Article
|
Cornea lymphatics drive the CD8+ T-cell response to herpes simplex virus-1.
|
Academic Article
|
Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system.
|
Academic Article
|
Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.
|
Academic Article
|
Colony Stimulating Factor-1 Receptor Expressing Cells Infiltrating the Cornea Control Corneal Nerve Degeneration in Response to HSV-1 Infection.
|
Academic Article
|
Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection.
|
Academic Article
|
Ocular Glands Become Infected Secondarily to Infectious Keratitis and Play a Role in Corneal Resistance to Infection.
|
Academic Article
|
The immune response to ocular herpes simplex virus type 1 infection.
|
Academic Article
|
An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
|
Academic Article
|
Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis.
|
Academic Article
|
Herpes simplex virus and the chemokines that mediate the inflammation.
|
Academic Article
|
OAS and PKR are not required for the antiviral effect of Ad:IFN-gamma against acute HSV-1 in primary trigeminal ganglia cultures.
|
Academic Article
|
Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system.
|
Academic Article
|
An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3.
|
Academic Article
|
Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
|
Academic Article
|
Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection.
|
Academic Article
|
Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.
|
Academic Article
|
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.
|
Academic Article
|
Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.
|
Academic Article
|
The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.
|
Academic Article
|
CXCL1-deficient mice are highly sensitive to pseudomonas aeruginosa but not herpes simplex virus type 1 corneal infection.
|
Academic Article
|
The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation.
|
Academic Article
|
Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.
|
Academic Article
|
Type I Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria.
|
Academic Article
|
Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection.
|
Academic Article
|
Herpes simplex virus-1 infects the olfactory bulb shortly following ocular infection and exhibits a long-term inflammatory profile in the form of effector and HSV-1-specific T cells.
|
Academic Article
|
Herpes Simplex Virus 1, Macrophages, and the Cornea.
|
Academic Article
|
Herpes Simplex Virus 1 (HSV-1) 0?NLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
|
Academic Article
|
Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.
|
Academic Article
|
Unforeseen consequences of IL-12 expression in the eye of GFAP-IL12 transgenic mice following herpes simplex virus type 1 infection.
|
Academic Article
|
The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.
|
Academic Article
|
Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection.
|
Academic Article
|
Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection.
|
Academic Article
|
The murine double-stranded RNA-dependent protein kinase PKR and the murine 2',5'-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture.
|
Academic Article
|
Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway.
|
Academic Article
|
Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection.
|
Academic Article
|
ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.
|
Academic Article
|
Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.
|
Academic Article
|
CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection.
|
Academic Article
|
Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection.
|
Academic Article
|
The role of chemokines during herpes simplex virus-1 infection.
|
Academic Article
|
Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection.
|
Academic Article
|
CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.
|
Academic Article
|
A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of Leukocytes.
|
Academic Article
|
PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection.
|
Academic Article
|
Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites.
|
Academic Article
|
Interferon-e protects the female reproductive tract from viral and bacterial infection.
|
Academic Article
|
Sphingolipids in ocular inflammation.
|
Academic Article
|
Enhanced resistance of CXCR3 deficient mice to ocular HSV-1 infection is due to control of replication in the brain ependyma.
|
Academic Article
|
Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.
|
Academic Article
|
Degeneration and regeneration of corneal nerves in response to HSV-1 infection.
|
Academic Article
|
Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.
|
Academic Article
|
Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?"
|
Academic Article
|
Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II.
|
Academic Article
|
Neuroretinal-Derived Caveolin-1 Promotes Endotoxin-Induced Inflammation in the Murine Retina.
|
Academic Article
|
Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta.
|
Academic Article
|
Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice.
|
Academic Article
|
Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta.
|
Academic Article
|
RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.
|
Academic Article
|
Transfection of Mülller cells with type I interferon transgenes: resistance to HSV-1 infection.
|
Academic Article
|
Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection.
|
Academic Article
|
Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10.
|
Academic Article
|
The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.
|
Academic Article
|
Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality.
|
Academic Article
|
Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.
|
Academic Article
|
CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system.
|
Academic Article
|
Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.
|
Academic Article
|
Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice.
|
Academic Article
|
CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.
|
Academic Article
|
Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?
|
Academic Article
|
HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response.
|
Academic Article
|
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells.
|
Academic Article
|
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
|
Academic Article
|
IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.
|
Academic Article
|
Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNa/ß Defense Pathways.
|
Academic Article
|
Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection.
|
Academic Article
|
The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.
|
Academic Article
|
Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity.
|
Grant
|
The Role of CXCL9 in Genital HSV-2 Infection
|
Grant
|
NEUROIMMUNOLOGY OF HSV-1 REACTIVATION
|
Grant
|
The Neuroimmunology of Viral Infection
|
Grant
|
NEUROIMMUNOLOGY OF AED IN OCULAR HSV-1 INFECTION
|
Grant
|
Anti-Viral Gene Delivery in the Nervous System
|
Academic Article
|
Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs.
|
Academic Article
|
Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0?NLS vaccine against ocular HSV-1 challenge.
|
Academic Article
|
An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.
|
Academic Article
|
The Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation.
|
Academic Article
|
The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0?NLS and 0?RING Is Lost over Time.
|
Academic Article
|
Tripartite-Motif 21 (TRIM21) Deficiency Results in a Modest Loss of Herpes Simplex Virus (HSV)-1 Surveillance in the Trigeminal Ganglia Following Cornea Infection.
|
Academic Article
|
Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0?NLS, against Herpes Simplex Virus 1.
|